Andromeda Surgical Develops Autonomous Surgery Technology
Andromeda Surgical is developing technology to make surgical procedures easier and more efficient. The company aims to elevate surgeon performance closer to expert levels through automation.
Andromeda Surgical is focusing on the automation of surgical procedures within endourology, a market segment valued at approximately $25 billion.
The company's objective is to simplify and enhance the efficiency of surgeries. "Our aim is for every surgeon to operate much closer to the level of the world expert for the procedure they are performing," stated CEO Nicholas Damiano in an interview with CB Insights.
By developing autonomous surgical technology, Andromeda Surgical seeks to improve the quality and accessibility of surgical interventions. The broader global market for surgical procedures is estimated to be around $4 trillion.
The technology is intended to address surgeon challenges by providing tools that enhance performance and reduce error potential, ultimately aiming to elevate overall surgical competency.